Hadassah Researchers Use Functional MRI to Detect Responsiveness in Unconscious Patients
"The clinical evaluation of consciousness in Disorder of Consciousness (DOC) patients, based on their exhibited behavior, is difficult and remains erroneous in many cases," report researchers at the Hadassah Medical Organization.
Aiming to determine the plausibility and challenges of implementing a clinical service to evaluate the consciousness level in patients suffering from (DOC), the researchers found via Functional MRI that different patients exhibited different degrees of responsiveness. They explain that recent studies demonstrate different levels of stimulus processing, as well as evidence of some level of awareness in sub-groups of these patients.
With 500 beds, 19 stories (five underground) and state-of-the-art technical equipment, the Tower is the most advanced medical facility in the Middle East.
The study was composed of 11 patients (ages 11-67), who were diagnosed as being in either vegetative or minimally conscious states. Using Functional MRI, researchers evaluated auditory, language, voice familiarity, imagery, and visual responsiveness.
The authors report: In 9 patients, they found auditory-related activation; however, only in 5 of the subjects was differential activation found for language. Six patients exhibited differential response to their own name. In three patients, a response to visual stimuli was identified. In one patient, the auditory and linguistic systems were clearly activated in a hierarchical pattern and, moreover, willful modulation of brain activity was identified in the imagery test.
Lead Author of the study was Atira S. Bick, coordinator of the clinical service in Hadassah's Functional MRI Unit. The original research article, entitled "Implementing Novel Imaging Methods for Improved Diagnosis of Disorder of Consciousness Patients", appears in the Journal of the Neurological Sciences, Volume 334, Issues 1–2, 15 November 2013, Pages 130-138.
Hadasit, Hadassah’s Technology Transfer Arm, Reviews
When the Hadassah University Medical Center’s physicians suggest a
solution to a medical problem which can lead to the development of a new
medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its
feasibility and supports the promotion of those viable ideas with innovation
potential. Although 2012 has been “a year full of challenges for the life
science industry,” says Einat Zisman, Hadasit’s Chief Executive Officer,
Hadasit still signed 125 agreements for clinical trials, all to be done at
Hadassah. In addition, Hadasit signed 15 agreements for cooperation and
commercialization of technologies that were developed at Hadassah. Click here
to read the latest Newsletter from Hadasit >>